MTOR and neoplasm: GSVA of the KEGG pathways revealed that the immune-related pathways, such as the T cell receptor pathway, were enriched in patients with low VARS1 expression, while tumor growth pathways such as the cell cycle pathway and the mTOR pathway were enriched in patients with high VARS1 expression (Fig. 8 A).